Cytarabine
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
Year introduced: 1966
PubMed search builder options
Subheadings:
Tree Number(s): D03.383.742.680.245.453, D13.570.065.300, D13.570.685.245.453
MeSH Unique ID: D003561
Registry Number: 04079A1RDZ
Entry Terms:
- Arabinofuranosylcytosine
- Arabinosylcytosine
- Aracytidine
- Cytosine Arabinoside
- Arabinoside, Cytosine
- Cytarabine Hydrochloride
- Cytosar
- Cytosar-U
- Cytosar U
- beta-Ara C
- beta Ara C
- Aracytine
- Ara-C
- Ara C
- Cytonal
See Also:
Pharmacologic Action: